Study tracks fertility and pregnancy in young breast cancer survivors
NCT ID NCT06756802
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at fertility, pregnancy, and contraception in women diagnosed with breast cancer between ages 18 and 50. Researchers will collect data from 22,000 patients to understand how cancer treatments affect their ability to have children and the health of their newborns. The goal is to improve future recommendations and care for young breast cancer survivors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better guidelines for fertility preservation and safer pregnancy planning after breast cancer treatment.
What could go wrong
This is an observational study, so it won't test a new treatment. Results may not apply to all patients or change practice directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Leon Berard
Lyon, 69000, France
-
Centre Oscar Lambret
Lille, 59000, France
-
Institut Curie
Paris, 75000, France
-
Institut de Cancerologie de L'Ouest
Saint-Herblain, 44805, France